Catalent, Inc.
↗Tampa, Florida, USA
Catalent is a leading global contract development and manufacturing organization (CDMO) that provides advanced delivery technologies, development, and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products. The company supports partners throughout the entire product life cycle, from early-stage development to commercial supply.
Following its acquisition by Novo Holdings A/S in December 2024, Catalent operates as a private, independent company. It maintains a vast global network of over 40 facilities, enabling it to support thousands of partner programs and supply billions of doses of life-enhancing treatments annually.
CLASSIFICATION
Company Type:CDMO
Therapeutic Areas:
Industry:CDMO
Sub-Industry:Pharmaceutical Manufacturing and Development
SIZE & FINANCIALS
Employees:10000+
Founded:2007
Ownership:subsidiary
Status:operating
FUNDING
Investors:Novo Holdings A/S
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Service provider)
Modalities:Small molecule, Biologics, Cell therapy, Gene therapy, ADC, siRNA
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Novo Holdings A/S
Acquired By:Novo Holdings A/S (2024-12-01)
Key Partnerships:SmartCella (iPSCs), Galapagos NV (CAR-T manufacturing), GelMEDIX (iPSC-derived cell therapies), Silexion Therapeutics (siRNA formulation)
COMPETITION
Position:Leader
Competitors:Recipharm, Lonza, Thermo Fisher Scientific (Patheon), Samsung Biologics
LEADERSHIP
Key Executives:
Alessandro Maselli - President and CEO
Board Members:Susan Mahony, Marie-France Tschudin, Tim Walbert
LINKS
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Catalent, Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Catalent, Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.